290 related articles for article (PubMed ID: 31770452)
1. Undergraduate and postgraduate pharmacovigilance education: A proposal for appropriate curriculum content.
Herrera Comoglio R
Br J Clin Pharmacol; 2020 Apr; 86(4):779-790. PubMed ID: 31770452
[TBL] [Abstract][Full Text] [Related]
2. What Future Healthcare Professionals Need to Know About Pharmacovigilance: Introduction of the WHO PV Core Curriculum for University Teaching with Focus on Clinical Aspects.
van Eekeren R; Rolfes L; Koster AS; Magro L; Parthasarathi G; Al Ramimmy H; Schutte T; Tanaka D; van Puijenbroek E; Härmark L
Drug Saf; 2018 Nov; 41(11):1003-1011. PubMed ID: 29949100
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
4. Medication Errors Associated With Adverse Drug Reactions in Iran (2015-2017): A P-Method Approach.
Karimian Z; Kheirandish M; Javidnikou N; Asghari G; Ahmadizar F; Dinarvand R
Int J Health Policy Manag; 2018 Dec; 7(12):1090-1096. PubMed ID: 30709084
[TBL] [Abstract][Full Text] [Related]
5. Knowledge, attitude, practice and barriers towards pharmacovigilance and adverse drug reactions reporting among healthcare professionals in Turkey: a systematic review.
Khan Z; Karatas Y; Martins MAP; Jamshed S; Rahman H
Curr Med Res Opin; 2022 Jan; 38(1):145-154. PubMed ID: 34694167
[TBL] [Abstract][Full Text] [Related]
6. Urgent need to modernize pharmacovigilance education in healthcare curricula: review of the literature.
Reumerman M; Tichelaar J; Piersma B; Richir MC; van Agtmael MA
Eur J Clin Pharmacol; 2018 Oct; 74(10):1235-1248. PubMed ID: 29926135
[TBL] [Abstract][Full Text] [Related]
7. Impact of a pharmacist-driven pharmacovigilance system in a secondary hospital in the Gauteng Province of South Africa.
Terblanche A; Meyer JC; Godman B; Summers RS
Hosp Pract (1995); 2018 Oct; 46(4):221-228. PubMed ID: 30092683
[TBL] [Abstract][Full Text] [Related]
8. [Recording and assessment of medication errors : Experience of the Drug Commission of the German Medical Association].
Köberle U; Stammschulte T; Gundert-Remy U; Pitzer M; Bräutigam K
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Sep; 61(9):1066-1074. PubMed ID: 30022236
[TBL] [Abstract][Full Text] [Related]
9. [Understanding and reducing the risk of adverse drug reactions in pediatric patients].
Gotta V; van den Anker J; Pfister M
Ther Umsch; 2015 Dec; 72(11-12):679-86. PubMed ID: 26654811
[TBL] [Abstract][Full Text] [Related]
10. Identifying and managing adverse drug reactions: Qualitative analysis of patient reports to the UK yellow card scheme.
O' Donovan B; Rodgers RM; Cox AR; Krska J
Br J Clin Pharmacol; 2022 Jul; 88(7):3434-3446. PubMed ID: 35128732
[TBL] [Abstract][Full Text] [Related]
11. Knowledge, awareness, perception and reporting of experienced adverse drug reactions among outpatients in Nigeria.
Adisa R; Adeniyi OR; Fakeye TO
Int J Clin Pharm; 2019 Aug; 41(4):1062-1073. PubMed ID: 31140162
[TBL] [Abstract][Full Text] [Related]
12. Pharmacovigilance practice among pediatric neurologists from Poland and Germany.
Kopciuch D; Kus K; Niśkiewicz I; Fliciński J; Zaprutko T; Ratajczak P; Nowakowska E; Hoffmann K; Koligat-Seitz A; Bryl W; Paczkowska A
BMC Med Educ; 2023 Aug; 23(1):547. PubMed ID: 37528387
[TBL] [Abstract][Full Text] [Related]
13. Teaching Pharmacovigilance to Undergraduate Students: Our Experience in Poor-Resource Setting.
Alshakka M; Badullah W; Al-Dhuraibi A; Alshagga S; Ibrahim MIM
J Pharm Bioallied Sci; 2022; 14(1):31-37. PubMed ID: 35784104
[TBL] [Abstract][Full Text] [Related]
14. [Adverse drug reactions and prescription errors: morbi-mortality].
Chaio S; Toibaro J; Valicenti P; Saidón P
Medicina (B Aires); 2013; 73(2):111-8. PubMed ID: 23570758
[TBL] [Abstract][Full Text] [Related]
15. Medical students as adverse drug event managers, learning about side effects while improving their reporting in clinical practice.
Reumerman M; Tichelaar J; Richir MC; van Agtmael MA
Naunyn Schmiedebergs Arch Pharmacol; 2021 Jul; 394(7):1467-1476. PubMed ID: 33666715
[TBL] [Abstract][Full Text] [Related]
16. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
Tandon VR; Mahajan V; Khajuria V; Gillani Z
Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
[TBL] [Abstract][Full Text] [Related]
17. Medical errors challenges for the health professionals: need of Pharmacovigilance to prevent.
Das BP; Rauniar GP; Bhattacharya SK
JNMA J Nepal Med Assoc; 2006; 45(162):273-8. PubMed ID: 18365356
[TBL] [Abstract][Full Text] [Related]
18. Frequency and Nature of Adverse Drug Reactions Due to Non-Prescription Drugs in Children: A Retrospective Analysis from the French Pharmacovigilance Database.
Durrieu G; Maupiler M; Rousseau V; Chebane L; Montastruc F; Bondon-Guitton E; Montastruc JL
Paediatr Drugs; 2018 Feb; 20(1):81-87. PubMed ID: 28766184
[TBL] [Abstract][Full Text] [Related]
19. A prospective analysis of the preventability of adverse drug reactions reported in Sweden.
Lövborg H; Eriksson LR; Jönsson AK; Bradley T; Hägg S
Eur J Clin Pharmacol; 2012 Aug; 68(8):1183-9. PubMed ID: 22349466
[TBL] [Abstract][Full Text] [Related]
20. Pharmacovigilance education to healthcare professionals: Will it affect their performance in reporting adverse drug reactions?
Ibrahim DM; Shawki MA; Solayman MH; Sabri NA
Int J Clin Pract; 2021 Nov; 75(11):e14731. PubMed ID: 34387008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
